American depository receipts of European stocks were 0.1% higher at 127.36 on the Bank of New York Mellon Europe ADR Index on Monday morning. Gainers in Continental Europe were led by Cellectis (CLLS), a French genome engineering company, 2.4% higher, followed by DBV Technologies (DBVT), a French clinical-stage biopharmaceutical company, up by 1.8% and Grifols (GRFS), a Spanish company engaged in the healthcare sector, also 1.8% higher. Nokia (NOK), a technology investor, was 1.3% higher.
In the UK, low-cost airline Ryanair (RYAAY) and gold miner Randgold Resources (GOLD), were both 1.1% higher, followed by CRH (CRH), a building materials company, up by 0.9% and Unilever (UL), a Dutch consumer goods company, 0.8% higher. Decliners in Continental Europe were led by Deutsche Bank – Global Registered Shares (DB), down by 2.9% and Edap (EDAP), a French medical devices developer, 1.5% lower and Logitech (LOGI), a Swiss hardware and software products developer, down by 1.1%. Nabriva Therapeutics (NBRV), an Austria-based clinical-stage biopharmaceutical company, was 1.0% lower.